ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies Ltd. (HYFT)

Market Closed
3 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
1. 35
+0.06
+4.6512%
Pre Market
$
1. 40
+0.05 +3.7037%
60.61M Market Cap
- P/E Ratio
- Div Yield
136,071 Volume
- Eps
$ 1.29
Previous Close
Investors:
Add Transaction
Day Range
1.25 1.39
Year Range
0.99 3.25
Want to track HYFT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MindWalk Holdings Corp. (HYFT) Q4 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q4 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q4 2026 Earnings Call Transcript

Seekingalpha | 1 week ago
MindWalk Holdings Corp. (HYFT) Reports Q4 Loss, Misses Revenue Estimates

MindWalk Holdings Corp. (HYFT) Reports Q4 Loss, Misses Revenue Estimates

MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.04 per share a year ago.

Zacks | 1 week ago
MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript

Seekingalpha | 4 months ago
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates

MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates

MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.

Zacks | 4 months ago
MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript

Seekingalpha | 7 months ago
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates

MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates

MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.07 per share a year ago.

Zacks | 7 months ago